芳香化酶抑制剂和灭活剂的临床药代动力学 - Suppr

Suppr

超能文献

Clinical pharmacokinetics of aromatase inhibitors and inactivators.

作者信息

Lønning Per

机构信息

Section of Oncology, Department of Medicine, University of Bergen, Haukeland University Hospital, Bergen, Norway.

出版信息

Clin Pharmacokinet. 2003;42(7):619-31. doi: 10.2165/00003088-200342070-00002.

DOI:10.2165/00003088-200342070-00002

PMID:12844324

Abstract

摘要

相似文献

Clinical pharmacokinetics of aromatase inhibitors and inactivators.芳香化酶抑制剂和灭活剂的临床药代动力学

Clin Pharmacokinet. 2003;42(7):619-31. doi: 10.2165/00003088-200342070-00002.

The effect of maraviroc on the pharmacokinetics of digoxin in healthy volunteers.马拉维若对健康志愿者中地高辛药代动力学的影响。

Clin Pharmacol Drug Dev. 2014 May;3(3):202-6. doi: 10.1002/cpdd.91. Epub 2014 Feb 6.

Interactions of antioestrogens and aromatase inhibitors.抗雌激素与芳香化酶抑制剂的相互作用。

Forum (Genova). 2002;12(1):45-59.

Are differences in the available aromatase inhibitors and inactivators significant?

Clin Cancer Res. 2001 Dec;7(12 Suppl):4360s-4368s; discussion 4411s-4412s.

Aromatase inhibitors and inactivators for breast cancer therapy.用于乳腺癌治疗的芳香化酶抑制剂和失活剂。

Drugs Aging. 2002;19(4):277-98. doi: 10.2165/00002512-200219040-00003.

Influence of cholestyramine on the pharmacokinetics of cerivastatin.考来烯胺对西立伐他汀药代动力学的影响。

Int J Clin Pharmacol Ther. 1997 Jun;35(6):250-4.

Influence of the antacid Maalox and the H2-antagonist cimetidine on the pharmacokinetics of cerivastatin.抗酸剂氢氧化铝镁混悬液和H2拮抗剂西咪替丁对西立伐他汀药代动力学的影响。

Int J Clin Pharmacol Ther. 1997 Jun;35(6):261-4.

Liarozole. Liarozole fumarate, Liazal, R 75251, R 85246.氯硝唑。富马酸氯硝唑，利扎唑，R 75251，R 85246。

Drugs R D. 1999 Dec;2(6):427-30. doi: 10.2165/00126839-199902060-00017.

Pharmacology and pharmacokinetics of the newer generation aromatase inhibitors.新一代芳香化酶抑制剂的药理学与药代动力学

Clin Cancer Res. 2003 Jan;9(1 Pt 2):468S-72S.

Valproic acid and risperidone.丙戊酸和利培酮。

J Am Acad Child Adolesc Psychiatry. 2001 Aug;40(8):866-7. doi: 10.1097/00004583-200108000-00003.

引用本文的文献

Clinical Efficacy, Pharmacokinetics, and Safety of the Available Medical Options in the Treatment of Endometriosis-Related Pelvic Pain: A Scoping Review.治疗子宫内膜异位症相关盆腔疼痛的现有医学选择的临床疗效、药代动力学及安全性：一项范围综述

Pharmaceuticals (Basel). 2023 Sep 18;16(9):1315. doi: 10.3390/ph16091315.

Sex-dependent effects of multiple acute concurrent stresses on memory: a role for hippocampal estrogens.多种急性并发应激对记忆的性别依赖性影响：海马雌激素的作用。

Front Behav Neurosci. 2022 Sep 8;16:984494. doi: 10.3389/fnbeh.2022.984494. eCollection 2022.

Bisindolylmaleimide IX: A novel anti-SARS-CoV2 agent targeting viral main protease 3CLpro demonstrated by virtual screening pipeline and in-vitro validation assays.双吲哚马来酰亚胺化合物 IX：一种通过虚拟筛选管道和体外验证试验靶向病毒主要蛋白酶 3CLpro 的新型抗 SARS-CoV2 药物。

Methods. 2021 Nov;195:57-71. doi: 10.1016/j.ymeth.2021.01.003. Epub 2021 Jan 14.

Letrozole : in postmenopausal hormone-responsive early-stage breast cancer.来曲唑：用于绝经后激素反应性早期乳腺癌。

Drugs. 2006;66(3):353-62. doi: 10.2165/00003495-200666030-00010.

Letrozole: a review of its use in postmenopausal women with breast cancer.来曲唑：用于绝经后乳腺癌妇女的综述。

Drugs. 2004;64(11):1213-30. doi: 10.2165/00003495-200464110-00006.

本文引用的文献

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial.阿那曲唑单药或联合他莫昔芬与单纯他莫昔芬用于绝经后早期乳腺癌妇女的辅助治疗：ATAC随机试验的初步结果。

Lancet. 2002 Jun 22;359(9324):2131-9. doi: 10.1016/s0140-6736(02)09088-8.

Aromatase inhibitors and inactivators for breast cancer therapy.用于乳腺癌治疗的芳香化酶抑制剂和失活剂。

Drugs Aging. 2002;19(4):277-98. doi: 10.2165/00002512-200219040-00003.

Antiaromatase agents: preclinical data and neoadjuvant therapy.抗芳香化酶药物：临床前数据与新辅助治疗

Clin Breast Cancer. 2000 Sep;1 Suppl 1:S9-14. doi: 10.3816/cbc.2000.s.002.

The potential for aromatase inhibition in breast cancer prevention.芳香化酶抑制在乳腺癌预防中的潜力。

Clin Cancer Res. 2001 Dec;7(12 Suppl):4423s-4428s; discussion 4411s-4412s.

Formestane, a steroidal aromatase inhibitor after failure of non-steroidal aromatase inhibitors (anastrozole and letrozole): is a clinical benefit still achievable?福美坦，一种在非甾体类芳香化酶抑制剂（阿那曲唑和来曲唑）治疗失败后使用的甾体类芳香化酶抑制剂：仍能实现临床获益吗？

Ann Oncol. 2001 Nov;12(11):1539-43. doi: 10.1023/a:1013180214359.

Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study.来曲唑对绝经后乳腺癌患者的术前治疗：一项随机双盲多中心研究。

Ann Oncol. 2001 Nov;12(11):1527-32. doi: 10.1023/a:1013128213451.

Influence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, cross-over study.来曲唑和阿那曲唑对绝经后乳腺癌患者全身芳香化作用及血浆雌激素水平的影响：一项随机交叉研究评估

J Clin Oncol. 2002 Feb 1;20(3):751-7. doi: 10.1200/JCO.2002.20.3.751.

Pharmacokinetics of anastrozole in Chinese male volunteers.阿那曲唑在中国男性志愿者中的药代动力学。

Acta Pharmacol Sin. 2001 Jun;22(6):573-6.

Effect of age and single versus multiple dose pharmacokinetics of letrozole (Femara) in breast cancer patients.

Biopharm Drug Dispos. 2001 Jul;22(5):191-7. doi: 10.1002/bdd.273.

Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma.在激素受体阳性晚期乳腺癌的一线治疗中，阿那曲唑优于他莫昔芬。

Cancer. 2001 Nov 1;92(9):2247-58. doi: 10.1002/1097-0142(20011101)92:9<2247::aid-cncr1570>3.0.co;2-y.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验